Total Payments
$6,825
2024 Payments
$2,074
Companies
37
Transactions
335
Medicare Patients
1,080
Medicare Billing
$51,823
Payment Breakdown by Category
Food & Beverage$6,470 (94.8%)
Travel$353.56 (5.2%)
Education$1.00 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,470 | 332 | 94.8% |
| Travel and Lodging | $353.56 | 2 | 5.2% |
| Education | $1.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,270 | 67 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $770.85 | 16 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $649.49 | 40 | $0 (2024) |
| Novo Nordisk Inc | $577.98 | 38 | $0 (2024) |
| PFIZER INC. | $513.21 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $468.21 | 16 | $0 (2024) |
| Lilly USA, LLC | $295.62 | 20 | $0 (2024) |
| Axsome Therapeutics, Inc. | $251.90 | 5 | $0 (2024) |
| Antares Pharma, Inc. | $231.63 | 10 | $0 (2024) |
| ITI, Inc. | $229.38 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,074 | 103 | ABBVIE INC. ($416.65) |
| 2023 | $1,673 | 85 | ABBVIE INC. ($350.12) |
| 2022 | $1,885 | 75 | Biohaven Pharmaceutical Holding Company Ltd. ($770.85) |
| 2021 | $1,192 | 72 | AbbVie Inc. ($257.23) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: PAIN | ||||||
| 12/10/2024 | ABBVIE INC. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTIBIOTIC | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Insomnia | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $61.20 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Obesity | ||||||
| 11/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $44.63 | General |
| Category: Central Nervous System | ||||||
| 11/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: Central Nervous System | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.77 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 322 | 501 | $26,792 | $14,876 |
| 2022 | 10 | 296 | 436 | $24,525 | $14,237 |
| 2021 | 9 | 243 | 332 | $20,290 | $11,348 |
| 2020 | 7 | 219 | 288 | $22,845 | $11,362 |
Total Patients
1,080
Total Services
1,557
Medicare Billing
$51,823
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 79 | $8,716 | $4,671 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 90 | $7,320 | $3,975 | 54.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 42 | $6,423 | $3,860 | 60.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,183 | $894.29 | 75.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 13 | $546.00 | $450.06 | 82.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 19 | 74 | $592.00 | $332.44 | 56.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 51 | 59 | $319.00 | $277.90 | 87.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 34 | $1,010 | $255.20 | 25.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 22 | $242.00 | $75.02 | 31.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $165.00 | $62.44 | 37.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 15 | 64 | $276.00 | $22.50 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 73 | $8,137 | $4,669 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 82 | $6,605 | $3,963 | 60.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 31 | $4,829 | $2,522 | 52.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 23 | 26 | $1,095 | $868.37 | 79.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,129 | $863.07 | 76.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 36 | $716.00 | $585.54 | 81.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 22 | 71 | $568.00 | $310.23 | 54.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 32 | $955.00 | $233.85 | 24.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 41 | 54 | $282.00 | $157.05 | 55.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 19 | $209.00 | $65.13 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 73 | $7,953 | $4,339 | 54.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 74 | $6,025 | $3,761 | 62.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 20 | $3,118 | $1,618 | 51.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $1,638 | $704.58 | 43.0% |
About Jack Hydrick, FNP
Jack Hydrick, FNP is a Family healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053382648.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jack Hydrick, FNP has received a total of $6,825 in payments from pharmaceutical and medical device companies, with $2,074 received in 2024. These payments were reported across 335 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,470).
As a Medicare-enrolled provider, Hydrick has provided services to 1,080 Medicare beneficiaries, totaling 1,557 services with total Medicare billing of $51,823. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Murfreesboro, TN
- Active Since 01/31/2006
- Last Updated 12/01/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1053382648
Products in Payments
- NURTEC ODT (Drug) $1,253
- VRAYLAR (Drug) $625.49
- REXULTI (Drug) $544.13
- UBRELVY (Drug) $501.07
- Austedo XR (Drug) $318.02
- CAPLYTA (Drug) $296.44
- AUSTEDO (Drug) $276.57
- Ozempic (Drug) $266.18
- Auvelity (Drug) $251.90
- Rybelsus (Drug) $186.49
- XYOSTED (Drug) $172.77
- XIFAXAN (Drug) $154.15
- QULIPTA (Drug) $131.21
- TRINTELLIX (Drug) $117.16
- EMGALITY (Drug) $110.47
- JARDIANCE (Drug) $102.17
- VYEPTI (Biological) $101.57
- Kerendia (Drug) $98.44
- SHINGRIX (Biological) $92.33
- NOCDURNA (Drug) $74.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Murfreesboro
Ms. Cynthia Miller, Fnp, FNP
Family — Payments: $322,765
Family $322,765
Melanie Mcghee, N.p, N.P
Family — Payments: $42,186
Family $42,186
Mary Fulghum, Np, NP
Family — Payments: $10,787
Family $10,787
Stephanie Rogers, Fnp-Bc, Apn, FNP-BC, APN
Family — Payments: $10,198
Family $10,198
Kristine Sherman
Family — Payments: $9,811
Family $9,811
Brooks Mabry, Ms, Apn, Fnp-Bc, MS, APN, FNP-BC
Family — Payments: $9,149
Family $9,149